Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

AbbVie Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term borrowings
Current portion of long-term debt and finance lease obligations
Accounts payable and accrued liabilities
Current liabilities
Long-term debt and finance lease obligations, excluding current portion
Deferred income taxes
Other long-term liabilities
Long-term liabilities
Total liabilities
Common stock, $0.01 par value
Common stock held in treasury, at cost
Additional paid-in-capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Stockholders’ equity (deficit)
Noncontrolling interest
Total equity (deficit)
Total liabilities and equity (deficit)

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Short-term borrowings
Short-term borrowings as a percentage of total liabilities and equity remained low and stable, generally near zero from 2020 through 2024, with a small spike to 1.17% at the end of the first quarter of 2025, indicating minimal reliance on short-term debt during most periods prior to that.
Current portion of long-term debt and finance lease obligations
This category experienced fluctuations without a clear trend, varying between approximately 2% and 8.9% of total liabilities and equity over the quarters. Notable increases occur at the end of 2021 and mid-2024, while a general decline is observed toward the first quarter of 2025.
Accounts payable and accrued liabilities
There is a consistent upward trend observed from around 13.9% in early 2020 to about 23% by early 2025. This suggests increasing obligations and accrued expenses relative to the company’s capital structure across the time span.
Current liabilities
Current liabilities as a percentage of total liabilities and equity increased steadily from about 18% in Q1 2020 to peak near 30% in late 2024, before slightly decreasing to roughly 27% in early 2025. This reflects a growing proportion of short-term obligations over the period.
Long-term debt and finance lease obligations, excluding current portion
The proportion of long-term debt steadily decreased from approximately 69.4% in early 2020 to a low near 38.8% in late 2021, followed by a period of moderate fluctuations around 40% to 47% from 2022 through early 2025, indicating strategic adjustments in long-term debt levels.
Deferred income taxes
Deferred income taxes showed a decline from just over 3% in mid-2020 to about 1.4%-1.9% through the latter years, maintaining relative stability with minor fluctuations, suggesting consistent tax deferral relationships.
Other long-term liabilities
This component remained relatively stable overall, oscillating mostly between 15.5% and 24%, with a gradual increase toward the later years, peaking near 24% in late 2023 and maintaining levels above 22% thereafter, reflecting other obligations not categorized as debt.
Long-term liabilities (aggregate)
Long-term liabilities as a whole decreased from approximately 90% in early 2020 to around 65%-72% in subsequent years, portraying a reduction in the company's reliance on long-term commitments balanced by relative stability post-2021.
Total liabilities
Total liabilities showed a downward shift from over 108% in early 2020 to about 87%-99% in later periods, indicating a possible reduction in leverage or changes in accounting equity classification during the time frame.
Common stock, $0.01 par value
The common stock proportion remained stable at roughly 0.01% to 0.02%, signifying minimal changes in par value equity relative to total liabilities and equity.
Common stock held in treasury, at cost
Treasury stock percentages fluctuated substantially early in the timeline, initially very negative at -27.53% in Q1 2020, then stabilizing around -1.3% to -3.3% through 2021, before declining steadily in subsequent years reaching approximately -6.7% by early 2025. This indicates increasing treasury stock holdings over time.
Additional paid-in capital
There was a consistent upward trend in additional paid-in capital from about 11% in early 2020 to over 16% by early 2025, reflecting increased equity injections or retained capital contributions beyond nominal stock value.
Retained earnings (accumulated deficit)
Retained earnings displayed volatility, initially positive or near zero until mid-2021, followed by a notable decline starting late 2022, turning negative from 2023 onward and reaching approximately -7% by early 2025. This suggests erosion in accumulated profits or increased accumulated deficits over recent years.
Accumulated other comprehensive loss
This item remained consistently negative but relatively stable between about -4% and -1%, indicating ongoing but limited comprehensive losses or adjustments outside net income over the observed periods.
Stockholders’ equity (deficit)
Equity as a proportion of total liabilities and equity was negative initially in early 2020 but turned positive and peaked near 12.4% in late 2022, followed by a declining trend to near 1% by early 2025. The decrease reflects deteriorating equity levels or increased liabilities impacting net equity.
Noncontrolling interest
Noncontrolling interest remained minimal throughout, around 0.01% to 0.03%, with a slight increase over time, signifying marginal outside shareholder involvement.
Total equity (deficit)
Total equity followed a pattern similar to stockholders’ equity, shifting from negative in early 2020 to a peak around 12.5% in late 2022, then declining steadily to about 1% by early 2025, mirroring the company's decreasing equity cushion relative to liabilities.
Total liabilities and equity (deficit)
This measure was consistently 100% by definition, serving as the baseline for relative comparisons and changes in individual components over time.